Latest for Geographic Atrophy
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Geographic Atrophy
The pathophysiology involves dysregulation of the complement system, a component of innate immunity, which drives chronic inflammation and progressive destruction of retinal tissue. Drusen (deposits of lipid and protein beneath the RPE) accumulate and activate complement cascades.
Keep reading about Geographic Atrophy
The first FDA-approved treatments specifically for geographic atrophy target this complement pathway: pegcetacoplan (SYFOVRE, Apellis) inhibits C3, and avacincaptad pegol (IZERVAY, Astellas/Iveric Bio) inhibits C5. Both are administered as intravitreal injections and have been shown to slow the rate of atrophy expansion, though they do not restore lost vision.
Geographic atrophy typically progresses over years, and maintaining regular monitoring with optical coherence tomography (OCT) is essential for tracking disease progression.
What are the symptoms of Geographic Atrophy?
These are common symptoms of Geographic Atrophy, and how strong they are varies from person to person.
- Dark or blank spots in the center of vision
- Difficulty reading or seeing fine details
- Colors appearing drab or less vibrant
- Difficulty seeing in dim lighting
- Gradual loss of central vision sharpness
- Increased difficulty recognizing faces
Who gets Geographic Atrophy?
Primarily affects adults over 60, with risk increasing significantly with age. More common in women and those of European descent. Risk factors include smoking, family history of AMD, cardiovascular disease, and UV light exposure.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Geographic Atrophy?
There are currently 2 FDA-approved medications for Geographic Atrophy.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Which new Geographic Atrophy medicines are in trials?
Investigational medicines Trial Friend tracks for Geographic Atrophy, with trial results, safety findings and where each one stands.
How to get help paying for Geographic Atrophy treatment
Charity funds and drugmaker programs for Geographic Atrophy, checked at the source.
- Izervay (Avacincaptad pegol) · IZERVAY My Way (Astellas)
- Syfovre (Pegcetacoplan (intravitreal)) · ApellisAssist
Every program and fund for Geographic Atrophy, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Geographic Atrophy
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Geographic Atrophy resources
Reputable organizations and medical references for learning more about Geographic Atrophy, including disease registries, foundation resources, and clinical guidelines.